Paradigm BioCapital Advisors LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 4:36 pm Purchase |
2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX |
Paradigm BioCapital Advisors LP | 4,738,929 5.000% |
4,738,929 (New Position) |
Filing |